Neuropeptide Y improves myocardial perfusion and function in a swine model of hypercholesterolemia and chronic myocardial ischemia

Journal of Molecular and Cellular Cardiology

Volumn 53, Issue 6, 2012, Pages 891-898

  Matyal, Robina ^a,b   Chu, Louis ^a,b   Mahmood, Feroze ^a,b   Robich, Michael P ^a,b   Wang, Angela ^a   Hess, Philip E ^a,b   Shahul, Sajid ^a,b   Pinto, Duane S ^a,b   Khabbaz, Kamal ^a,b   Sellke, Frank W ^b,c,d  

^a BETH ISRAEL DEACONESS MEDICAL CENTER   (United States)

^b HARVARD MEDICAL SCHOOL   (United States)

^c RHODE ISLAND HOSPITAL   (United States)

^d BROWN UNIVERSITY   (United States)

Author keywords

Angiogenesis; Chronic ischemia; Metabolic syndrome; Neuropeptide Y

Indexed keywords

NEUROPEPTIDE Y; NEUROPEPTIDE Y [3-36]; NEUROPEPTIDE Y RECEPTOR; UNCLASSIFIED DRUG;

ANGIOGENESIS; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; COLLATERAL CIRCULATION; CONTROLLED STUDY; HEART FUNCTION; HEART MUSCLE BLOOD FLOW; HEART MUSCLE ISCHEMIA; HEART MUSCLE PERFUSION; HYPERCHOLESTEROLEMIA; MALE; METABOLIC SYNDROME X; NONHUMAN; PRIORITY JOURNAL;

ANGIOGENESIS INDUCING AGENTS; ANIMALS; CORONARY ANGIOGRAPHY; CORONARY CIRCULATION; DISEASE MODELS, ANIMAL; HYPERCHOLESTEROLEMIA; MALE; MYOCARDIAL ISCHEMIA; MYOCARDIUM; NEUROPEPTIDE Y; RECEPTORS, NEUROPEPTIDE Y; SWINE;

HARNESS; SUIDAE;

EID: 84869086514     PISSN: 00222828     EISSN: 10958584     Source Type: Journal    
DOI: 10.1016/j.yjmcc.2012.08.027     Document Type: Article

References (39)

1. Pung Y.F., Chilian W.M. Corruption of coronary collateral growth in metabolic syndrome: role of oxidative stress. World J Cardiol 2010, 2:421-427.
2. D'Amore P.A., Ng Y.S. Won't you be my neighbor? Local induction of arteriogenesis. Cell 2002, 110:289-292.
3. Lassaletta A.D., Chu L.M., Sellke F.W. Therapeutic neovascularization for coronary disease: current state and future prospects. Basic Res Cardiol 2011, 106:897-909.
4. Beohar N., Rapp J., Pandya S., Losordo D.W. Rebuilding the damaged heart: the potential of cytokines and growth factors in the treatment of ischemic heart disease. J Am Coll Cardiol 2010, 56:1287-1297.
5. Rosinberg A., Khan T.A., Sellke F.W., Laham R.J. Therapeutic angiogenesis for myocardial ischemia. Expert Rev Cardiovasc Ther 2004, 2:271-283.
6. Greenberg J.I., Shields D.J., Barillas S.G., Acevedo L.M., Murphy E., Huang J., et al. A role for VEGF as a negative regulator of pericyte function and vessel maturation. Nature 2008, 456:809-813.
7. Granger H.J., Ziche M., Hawker J.R., Meininger C.J., Czisny L.E., Zawieja D.C. Molecular and cellular basis of myocardial angiogenesis. Cell Mol Biol Res 1994, 40:81-85.
8. Tirziu D., Simons M. Angiogenesis in the human heart: gene and cell therapy. Angiogenesis 2005, 8:241-251.
9. Khurana R., Simons M., Martin J.F., Zachary I.C. Role of angiogenesis in cardiovascular disease: a critical appraisal. Circulation 2005, 112:1813-1824.
10. Laham R.J., Rezaee M., Post M., Novicki D., Sellke F.W., Pearlman J.D., et al. Intrapericardial delivery of fibroblast growth factor-2 induces neovascularization in a porcine model of chronic myocardial ischemia. J Pharmacol Exp Ther 2000, 292:795-802.
11. Caporali A., Meloni M., Vollenkle C., Bonci D., Sala-Newby G.B., Addis R., et al. Deregulation of microRNA-503 contributes to diabetes mellitus-induced impairment of endothelial function and reparative angiogenesis after limb ischemia. Circulation 2011, 123:282-291.
12. Sellke F.W., Ruel M. Vascular growth factors and angiogenesis in cardiac surgery. Ann Thorac Surg 2003, 75:S685-S690.
13. Sodha N.R., Boodhwani M., Clements R.T., Xu S.H., Khabbaz K.R., Sellke F.W. Increased antiangiogenic protein expression in the skeletal muscle of diabetic swine and patients. Arch Surg 2008, 143:463-470.
14. Matyal R., Mahmood F., Robich M., Glazer H., Khabbaz K., Hess P., et al. Chronic type II diabetes mellitus leads to changes in neuropeptide Y receptor expression and distribution in human myocardial tissue. Eur J Pharmacol 2011, 665:19-28.
15. Mukouyama Y.S., Shin D., Britsch S., Taniguchi M., Anderson D.J. Sensory nerves determine the pattern of arterial differentiation and blood vessel branching in the skin. Cell 2002, 109:693-705.
16. Zukowska-Grojec Z., Karwatowska-Prokopczuk E., Rose W., Rone J., Movafagh S., Ji H., et al. Neuropeptide Y: a novel angiogenic factor from the sympathetic nerves and endothelium. Circ Res 1998, 83:187-195.
17. Alston E.N., Parrish D.C., Hasan W., Tharp K., Pahlmeyer L., Habecker B.A. Cardiac ischemia-reperfusion regulates sympathetic neuropeptide expression through gp130-dependent and independent mechanisms. Neuropeptides 2011, 45:33-42.
18. Cruze C.A., Su F., Limberg B.J., Deutsch A.J., Stoffolano P.J., Dai H.J., et al. The Y2 receptor mediates increases in collateral-dependent blood flow in a model of peripheral arterial insufficiency. Peptides 2007, 28:269-280.
19. Abe K., Tilan J.U., Zukowska Z. NPY and NPY receptors in vascular remodeling. Curr Top Med Chem 2007, 7:1704-1709.
20. Chen J.X., Stinnett A. Disruption of Ang-1/Tie-2 signaling contributes to the impaired myocardial vascular maturation and angiogenesis in type II diabetic mice. Arterioscler Thromb Vasc Biol 2008, 28:1606-1613.
21. Lee E.W., Michalkiewicz M., Kitlinska J., Kalezic I., Switalska H., Yoo P., et al. Neuropeptide Y induces ischemic angiogenesis and restores function of ischemic skeletal muscles. J Clin Invest 2003, 111:1853-1862.
22. Ghersi G., Chen W., Lee E.W., Zukowska Z. Critical role of dipeptidyl peptidase IV in neuropeptide Y-mediated endothelial cell migration in response to wounding. Peptides 2001, 22:453-458.
23. Robich M.P., Matyal R., Chu L.M., Feng J., Xu S.H., Laham R.J., et al. Effects of neuropeptide Y on collateral development in a swine model of chronic myocardial ischemia. J Mol Cell Cardiol 2010, 49:1022-1030.
24. Lind H., Erlinge D., Brunkwall J., Edvinsson L. Selective attenuation of neuropeptide-Y-mediated contractile responses in blood vessels from patients with diabetes mellitus. Clin Auton Res 1995, 5:191-197.
25. Robich M.P., Osipov R.M., Chu L.M., Han Y., Feng J., Nezafat R., et al. Resveratrol modifies risk factors for coronary artery disease in swine with metabolic syndrome and myocardial ischemia. Eur J Pharmacol 2011, 664:45-53.
26. Sodha N.R., Clements R.T., Feng J., Liu Y., Bianchi C., Horvath E.M., et al. The effects of therapeutic sulfide on myocardial apoptosis in response to ischemia-reperfusion injury. Eur J Cardiothorac Surg 2008, 33:906-913.
27. Boodhwani M., Voisine P., Ruel M., Sodha N.R., Feng J., Xu S.H., et al. Comparison of vascular endothelial growth factor and fibroblast growth factor-2 in a swine model of endothelial dysfunction. Eur J Cardiothorac Surg 2008, 33:645-650. [discussion 251-2].
28. Lee E.W., Grant D.S., Movafagh S., Zukowska Z. Impaired angiogenesis in neuropeptide Y (NPY)-Y2 receptor knockout mice. Peptides 2003, 24:99-106.
29. Zukowska Z., Grant D.S., Lee E.W. Neuropeptide Y: a novel mechanism for ischemic angiogenesis. Trends Cardiovasc Med 2003, 13:86-92.
30. Kupatt C., Hinkel R., Pfosser A., El-Aouni C., Wuchrer A., Fritz A., et al. Cotransfection of vascular endothelial growth factor-A and platelet-derived growth factor-B via recombinant adeno-associated virus resolves chronic ischemic malperfusion role of vessel maturation. J Am Coll Cardiol 2010, 56:414-422.
31. Protas L., Qu J., Robinson R.B. Neuropeptide Y: neurotransmitter or trophic factor in the heart?. News Physiol Sci 2003, 18:181-185.
32. Weihrauch D., Lohr N.L., Mraovic B., Ludwig L.M., Chilian W.M., Pagel P.S., et al. Chronic hyperglycemia attenuates coronary collateral development and impairs proliferative properties of myocardial interstitial fluid by production of angiostatin. Circulation 2004, 109:2343-2348.
33. Sodha N.R., Clements R.T., Boodhwani M., Xu S.H., Laham R.J., Bianchi C., et al. Endostatin and angiostatin are increased in diabetic patients with coronary artery disease and associated with impaired coronary collateral formation. Am J Physiol Heart Circ Physiol 2009, 296:H428-H434.
34. Boodhwani M., Nakai Y., Mieno S., Voisine P., Bianchi C., Araujo E.G., et al. Hypercholesterolemia impairs the myocardial angiogenic response in a swine model of chronic ischemia: role of endostatin and oxidative stress. Ann Thorac Surg 2006, 81:634-641.
35. Sheriff S., Ali M., Yahya A., Haider K.H., Balasubramaniam A., Amlal H. Neuropeptide Y Y5 receptor promotes cell growth through extracellular signal-regulated kinase signaling and cyclic AMP inhibition in a human breast cancer cell line. Mol Cancer Res 2010, 8:604-614.
36. Krichavsky M.Z., Losordo D.W. Prevention and recovery of hibernating myocardium by microvascular repair. Circulation 2011, 124:998-1000.
37. Barouch L.A., Gao D., Chen L., Miller K.L., Xu W., Phan A.C., et al. Cardiac myocyte apoptosis is associated with increased DNA damage and decreased survival in murine models of obesity. Circ Res 2006, 98:119-124.
38. Eddy D.M., Schlessinger L., Heikes K. The metabolic syndrome and cardiovascular risk: implications for clinical practice. Int J Obes (Lond) 2008, 32(Suppl. 2):S5-S10.
39. Wang Y., Zhang D., Ashraf M., Zhao T., Huang W., Ashraf A., et al. Combining neuropeptide Y and mesenchymal stem cells reverses remodeling after myocardial infarction. Am J Physiol Heart Circ Physiol 2010, 298:H275-H286.